Literature DB >> 12814969

Kinetic study on the reaction of cisplatin with metallothionein.

Douglas Hagrman1, Jerry Goodisman, James C Dabrowiak, Abdul-Kader Souid.   

Abstract

The binding of cisplatin to metallothionein (MT) was investigated at 37 degrees C in 10 mM Tris-NO3 (pH approximately 7.4) and 4.62 mM NaCl. The conditions were chosen to mimic passage of clinical concentrations of cisplatin through the cytosol. The reactions were monitored by high-performance liquid chromatography (HPLC), atomic absorption spectroscopy, and ultraviolet (UV) absorption spectroscopy. The UV data showed that several reactions occur, the first of which does not affect the absorbance (no Pt-sulfur bond formation). They also suggested that if [cisplatin] is large compared with [MT], the rate of subsequent reaction is between first and second order in [cisplatin] and between zeroth and first order in [MT]. HPLC eluates with 24 < retention time (tR) < 27 min contained undialyzable Pt, which increased with reaction time and corresponded to Pt-thionein product. Eluates with 3 < tR < 7 min corresponded to unbound cisplatin and allowed determination of second-order rate constants (k), using the second-order rate equation. The k value for cisplatin reacting with apo-MT was approximately 0.14 M-1 s-1, Cd/Zn-MT approximately 0.75 M-1 s-1, Cd7-MT approximately 0.53 M-1 s-1, and Zn7-MT approximately 0.65 M-1 s-1. Thus, cisplatin displaced Cd and Zn equally well. Leukocyte MT concentration was approximately 1.0 mM, so that the kinetics of cisplatin binding to cellular MT is pseudo-first order (pseudo-first-order rate constant, approximately 0.63 x 10-3 s-1; half-life, approximately 18 min). With [cisplatin] = 10 microM, the rate of cisplatin reaction with MT is approximately 6.3 micromol s-1 cm-3. We conclude that cellular MT can trap significant amounts of cisplatin and may efficiently contribute to cisplatin resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12814969     DOI: 10.1124/dmd.31.7.916

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  22 in total

1.  Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients.

Authors:  Paweł Surowiak; Verena Materna; Irina Kaplenko; Marek Spaczyński; Manfred Dietel; Hermann Lage; Maciej Zabel
Journal:  Virchows Arch       Date:  2005-06-21       Impact factor: 4.064

2.  In vitro effects of platinum compounds on renal cellular respiration in mice.

Authors:  Saeeda-S Almarzooqi; Ali-S Alfazari; Hidaya-M Abdul-Kader; Dhanya Saraswathiamma; Alia-S Albawardi; Abdul-Kader Souid
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

3.  Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin.

Authors:  Robert F Murphy; Edina Komlodi-Pasztor; Robert Robey; Frank M Balis; Nicholas P Farrell; Tito Fojo
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

4.  The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin.

Authors:  Nataliya V Dolgova; Doug Olson; Svetlana Lutsenko; Oleg Y Dmitriev
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

5.  Cellular responses to Cisplatin-induced DNA damage.

Authors:  Alakananda Basu; Soumya Krishnamurthy
Journal:  J Nucleic Acids       Date:  2010-08-08

6.  Insight into the toxic effects of cis-dichloridoplatinum(II) complexes containing 7-azaindole halogeno derivatives in tumor cells.

Authors:  Tereza Muchova; Jitka Pracharova; Pavel Starha; Radana Olivova; Oldrich Vrana; Barbora Benesova; Jana Kasparkova; Zdenek Travnicek; Viktor Brabec
Journal:  J Biol Inorg Chem       Date:  2013-05-15       Impact factor: 3.358

7.  Reaction of human metallothionein-3 with cisplatin and transplatin.

Authors:  Andrei V Karotki; Milan Vasák
Journal:  J Biol Inorg Chem       Date:  2009-06-18       Impact factor: 3.358

Review 8.  Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss.

Authors:  Lilun Li; Tiffany Chao; Jason Brant; Bert O'Malley; Andrew Tsourkas; Daqing Li
Journal:  Adv Drug Deliv Rev       Date:  2016-01-12       Impact factor: 15.470

9.  Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles.

Authors:  Lenka Zerzankova; Tereza Suchankova; Oldrich Vrana; Nicholas P Farrell; Viktor Brabec; Jana Kasparkova
Journal:  Biochem Pharmacol       Date:  2009-08-12       Impact factor: 5.858

10.  Role of ZIP8 in regulation of cisplatin sensitivity through Bcl-2.

Authors:  Xiangrong Geng; Liu Liu; Kan-Jen Tsai; Zijuan Liu
Journal:  Toxicol Appl Pharmacol       Date:  2018-10-17       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.